Orchard Therapeutics PLC (ORTX) has released an update to notify the public and investors about a material modification to rights of security holders.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Kyowa Kirin International plc acquired all outstanding Company Ordinary Shares at the Effective Time, following the provisions of the Scheme of Arrangement and England and Wales laws. Consequently, shareholders no longer have rights in the Company Ordinary Shares, retaining only the rights provided by the Scheme of Arrangement, which includes the entitlement to the Merger Consideration.
For further insights into ORTX stock, check out TipRanks’ Stock Analysis page.
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue